Jaguar Health, Inc. (JAGX)
NASDAQ: JAGX · Real-Time Price · USD
3.110
+0.200 (6.87%)
At close: May 26, 2026, 4:00 PM EDT
3.055
-0.055 (-1.77%)
Pre-market: May 27, 2026, 5:54 AM EDT

Jaguar Health Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
26134416
Market Cap Growth
-70.51%-51.31%259.99%-9.73%-74.93%-43.29%
Enterprise Value
28.9150.0343.2633.9232.2928.7
Last Close Price
3.1132.59883.752651.25114056.001365000.00
PS Ratio
0.060.561.140.380.343.78
PB Ratio
--0.381.830.75-6.251.41
P/TBV Ratio
-0.04-0.131.020.24-4.341.34
EV/Sales Ratio
0.984.353.703.482.706.62
Debt / Equity Ratio
-2.16-2.324.037.50-25.332.46
Net Debt / Equity Ratio
-1.91-2.473.926.17-44.701.06
Net Debt / EBITDA Ratio
-1.11-0.97-0.99-0.95-0.90-0.32
Net Debt / FCF Ratio
-3.59-1.80-0.97-0.92-0.88-0.36
Asset Turnover
0.780.250.220.200.240.09
Inventory Turnover
0.540.400.200.250.340.61
Quick Ratio
0.190.070.490.620.261.24
Current Ratio
0.500.501.632.000.741.84
Return on Equity (ROE)
201.38%1112.31%-565.74%-2366.62%-922.07%-362.07%
Return on Assets (ROA)
-69.45%-100.07%-59.18%-69.83%-68.34%-84.71%
Return on Invested Capital (ROIC)
-114.49%-146.37%-83.61%-107.95%-131.91%-163.92%
Return on Capital Employed (ROCE)
942.32%-292.50%-87.47%-127.27%-125.36%-120.76%
Buyback Yield / Dilution
-1474.87%-691.89%-1809.95%-1663.72%-119.99%-247.08%
Total Shareholder Return
-1474.87%-691.89%-1809.95%-1663.72%-119.99%-247.08%
Updated May 20, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q